Ginkgo Bioworks Holdings (DNABW) Exchange Rate Effect (2021 - 2026)
Ginkgo Bioworks Holdings (DNABW) reported Exchange Rate Effect of -$129000.0 for Q1 2026, down 274.32% on a YoY basis from $74000.0 in Q1 2025, and up 15.13% quarter-over-quarter from -$152000.0 in Q4 2025.
Ginkgo Bioworks Holdings (DNABW) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Ginkgo Bioworks Holdings has reported Exchange Rate Effect for 6 years, with the latest figure at -$129000.0 in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 274.32% year-over-year to -$129000.0; the trailing twelve-month figure through Mar 2026 stood at -$2000.0 (up 96.0% YoY), and the FY2025 full-year result was $201000.0, up 171.53% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$129000.0, up from -$152000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.1 million in Q4 2022, with the low at -$469000.0 in Q2 2023.
- Historically, Exchange Rate Effect has averaged $6529.4 across 5 years, with a median of -$35000.0 in 2024.
- The largest YoY upside for Exchange Rate Effect was 10090.91% in 2022 against a maximum downside of 987.5% in 2022.
- Ginkgo Bioworks Holdings' Exchange Rate Effect stood at $1.1 million in 2022, then sank by 90.72% to $102000.0 in 2023, then plunged by 171.57% to -$73000.0 in 2024, then sank by 108.22% to -$152000.0 in 2025, then gained by 15.13% to -$129000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$129000.0 (Q1 2026), -$152000.0 (Q4 2025), and $93000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | Ginkgo Bioworks Holdings | - | - | 16.38 Mn | -129,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -129,000.00 |
| Mar 31, 2026 | -129,000.00 |
| Dec 31, 2025 | -152,000.00 |
| Dec 31, 2025 | -152,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Sep 30, 2025 | 93,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Jun 30, 2025 | 186,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Dec 31, 2024 | -73,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Sep 30, 2024 | -35,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Jun 30, 2024 | -16,000.00 |
| Mar 31, 2024 | -157,000.00 |
| Mar 31, 2024 | -157,000.00 |
| Dec 31, 2023 | 102,000.00 |
| Dec 31, 2023 | 102,000.00 |